Isn't that the one where the SEC weirdly said the FDA wouldn't be happy with Cytodyn saying leronlimab worked in it's quarterly filings because they hadn't gotten the drug approved yet? They addressed that although, technically, they were within their rights to report their interpretation of the outcome of the study. They weren't making false claims about efficacy to patients. That stuff was used to take down some hemp gummy websites. It was dumb to try to apply it to leronlimab